Study testing how common lung infections relate to CF gene status
Part of Infections, Lungs & breathing clinical trials.
This study looks at whether carrying one CF gene (being a “CF carrier”) changes the risk of getting respiratory infections. It may help researchers understand how genetics can affect lung health, even for people who do not have cystic fibrosis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have already had genetic testing that showed you are a CF carrier, or you tested negative for CF/CF disease (for the comparison group).
- The study team needs you to speak and read English.
- You must not be sick right now with a respiratory infection (like a current chest cold or flu).
- You must not be incarcerated (prisoner status).
- You must be able to provide your own written informed consent (sign your own consent form).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether people who carry one cystic fibrosis (CF) gene change have differences in the kidneys and pancreas. You may be able to help researchers learn early effects and better health monitoring for CF carriers.
This study looks for a possible genetic link to heat stroke. Researchers will compare heat responses in people who carry the cystic fibrosis gene against those who do not.
This study follows children (age 5+) and adults with bronchiectasis or ongoing/repeated lung infections to learn what makes infections more likely. It mainly looks at non–cystic fibrosis causes, but may include some related conditions to compare differences.
This study tests a new method to detect bacteria in the lungs of people with cystic fibrosis (CF) by analyzing mucus samples. It aims to improve how we diagnose and treat lung infections.
This study looks at special blood markers in people with cystic fibrosis who have or haven't been treated for a lung infection caused by nontuberculous mycobacteria. The goal is to better understand the body's response, which could lead to better treatments.
This study looks at how a child’s early lung function, viral infections, and gut (microbiome) changes affect cystic fibrosis over time. It may help doctors understand what predicts how lung disease develops, which could improve future care.
Hear when a new Carrier State trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.